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Previewsnote, these modified clones are not
strictly isogenic relative to their parental
lines because they also appear to have
acquired other genetic variation during
clonal expansion, which may account for
many of the SNVs and indels discovered.
Additional studies in which more cell
clones modified by nucleases targeted
to different sites will be needed to further
assess the generality of these findings.
Importantly, the full genome-wide
spectrum of off-target mutations induced
by engineered nucleases remains as yet
undefined by these studies. WGS is un-
likely to fully address this important issue
for at least two reasons. First, as observed
by Veres et al. and Suzuki et al., system-
atic sequencing artifacts can make it
difficult to discern nuclease-induced al-
terations, even with high fold-coverage
sequencing, and bioinformatic filtering
strategies can also remove some bona
fide mutations as well (Suzuki et al.,
2014). Second, WGS is currently imprac-
tical for identifying lower frequency off-
target mutations. For example, there is
only a 95% probability of identifying off-
target sites that are mutated with a fre-
quency of 40% when sequencing three
diploid single-cell clones (as was done
by Veres et al.), and off-target mutations
that occur with more modest frequencies,4 Cell Stem Cell 15, July 3, 2014 ª2014 Elsevsuch as 10%, would routinely be missed
in such experiments. Indeed, to have
a 95% chance of finding off-target muta-
tions that occur with frequencies of
10%, 1%, or 0.1% at least once, one
would need to sequence 15, 150, or
1,500 diploid single-cell clones, respec-
tively. Furthermore, the actual number
of genomes that would need to be
sequenced is higher because convinc-
ingly distinguishing bona fide nuclease-
induced mutations from those acquired
by routine culture of cells requires identi-
fying indels at a given site more than
once among a population of genomes.
Clearly, an unbiased, genome-wide
method that is also sensitive enough to
identify even lower frequency off-target ef-
fects is required toglobally definedesigner
nuclease specificities. While the field
awaits description of such an approach,
the findings of Veres et al., Suzuki et al.,
Smith et al., and Kiskinis et al. take an
important step forward in showing that it
is possible to identify individual nuclease-
modified cell lines that bear few, if any,
unwanted nuclease-induced alterations.
These findings will undoubtedly spur
further research on the use of genome-
edited human PSCs for disease modeling
and of genome-edited single-cell clones
for potential therapeutic applications.ier Inc.ACKNOWLEDGMENTS
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Human induced pluripotent stem cells represent a promising tool for investigating the underlying causes of
disease; however, this potential currently remains unfulfilled. In this issue of Cell Stem Cell, Yoon et al. (2014)
used iPSCs derived from patients harboring common genetic risk variants as the starting point to discover
novel insights into disease pathology.The successful reprograming of somatic
cells into induced pluripotent stem cells
(iPSCs) by Takahashi and Yamanaka
in 2006 was seen as a landmark event indisease research. This new technology
promised to provide a powerful tool for
modeling human pathology that could be
used to understand the underlying causesof various human diseases. The following
years saw a stream of new and improved
approaches for converting somatic cells
into more differentiated cell types such
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Figure 1. Road Map to Discovery with iPSCs (15q11.2)
Amultifaceted approach to understand disease pathology with human-derived iPSCs as the starting point to discover novel phenotypes and candidate genes is
illustrated. In vivo function of the candidate genes can be studied using mouse brain development followed by determination of the molecular mechanism(s).
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Previewsas neurons. However, until recently the
iPSC technology was mostly used as a
tool to confirm previously identified phe-
notypes thought to underlie disease etiol-
ogy. In this issue of Cell Stem Cell, Song
and colleagues (Yoon et al., 2014) make
a significant advance in the application
of iPSCs by using patient-derived cells
as the entry point for discovering novel
pathophysiological phenotypes associ-
ated with neurological disease (Figure 1).
To achieve this they utilized iPSCs con-
taining a DNA deletion at chromosome
15q11.2 (15q11.2del), a region known to
be a prominent risk factor for schizo-
phrenia and autism spectrum disorder
(ASD) (Malhotra and Sebat, 2012).
Song and colleagues first established
iPSC lines using skin cells from
three individuals carrying heterozygous
15q11.2del. These iPSC lines were thendifferentiated into cortical neural rosettes
composed of human neural stem/progen-
itor cells (hNPCs) to understand how
15q11.2del could affect human brain
development. Careful examination of the
neural rosettes derived from patient cells,
using atypical PKCl and N-cadherin as
markers, showed disruption of apical-
basal polarity and adherens junctions of
these hNPCs. During embryonic cortical
development, correct organization of
apical-basal polarity and maintenance of
adherens junctions in neural progenitors
ensures proper cell division in the ventric-
ular zone (VZ) (Buchman and Tsai, 2007).
This tightly controlled process is impor-
tant for correct spatial development of
the cortex and disruption of this organiza-
tion has been implicated in the pathology
of diseases such as schizophrenia and
ASD (Durak et al., 2014; Ishizuka et al.,Cell Stem2011). The 15q11.2 region contains four
genes including CYFIP1, TUBGCP5 (also
known as GPC5), NIPA2, and NIPA1;
however, which of these could be respon-
sible for the observed apical-basal polar-
ity phenotype was unknown.
A likely candidate is CYFIP1, a protein
that has previously been shown to
regulate the WAVE complex, which is
important for actin cytoskeleton organiza-
tion (Silva et al., 2009). Song and col-
leagues have shown that CYFIP1 indeed
binds to the WAVE complex proteins
WAVE1, WAVE2, and NAP1 in hNPCs
from normal/control patients. Interest-
ingly, the authors found that WAVE2
protein, but not mRNA levels, was signifi-
cantly reduced in hNPCs derived from
15q11.2del patients, indicating that
CYFIP1 is important for stabilization of
the complex.Cell 15, July 3, 2014 ª2014 Elsevier Inc. 5
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PreviewsThe authors demonstrated that knock-
down of CYFIP1 in control cell lines re-
sulted in scattered expression of atypical
PKCl. Furthermore, restoration of normal
levels of CYFIP1 in 15q11.2del cell lines
was able to rescue the proper expression
of atypical PKCl at the luminal surface of
neural rosettes. Importantly, it was shown
that disruption of apical-basal polarity
was specific to 15q11.2del cell lines as
neural rosettes derived from cells carrying
mutations in DISC1, another prominent
psychiatric risk gene, did not exhibit
similar phenotypes.
The authors then complimented these
findings from patient-derived iPSCs with
experiments to examine the role of
CYFIP1 in mouse cortical development
in vivo. This was important because the
in vitro human iPSC system provides a
simple monolayer cell culture tool lacking
the tightly regulated in vivo transcriptional
program that gives rise to the complex
layeredmammaliancortex. Knockdownof
CYFIP1 in Radial glial cells (RGCs) using
the in utero electroporation technique re-
sulted in disorganized adherens junctions
similar to the phenotype observed in
15q11.2del-derived iPSCs. Furthermore,
they showed that depletion of CYFIP1 in
RGCs resulted in aberrant localization of
neural progenitors outside of VZ without
affecting the proliferative properties of
RGCs, suggesting that CYFIP1 is required
for proper localization of RGCs, but not
proliferation. Investigation of postnatal
day 5 mouse cortices after knockdown
of CYFIP1 in RGCs at embryonic day
13.5 revealed disorganization of cortical
layer formation. Finally, it was demon-
strated that CYFIP1 is a component of
the WAVE complex in mouse NPCs and
disruption of this complex resulted in
aberrant placement of RGCs in the devel-
oping mouse cortex. These results sug-
gest a conserved role for WAVE complex
proteins in determining apical-basal po-
larity in both human and mouse NPCs.
A leading hypothesis for the etiologies
of disorders such as schizophrenia and
ASD is that defects during early brain
development can lead to altered circuit
formation, thus predisposing the brain to
dysfunction during postnatal life (Fatemi
and Folsom, 2009). Consistent with this
notion, disruption of cortical structure
and networks have been suggested to6 Cell Stem Cell 15, July 3, 2014 ª2014 Elsevunderlie schizophrenia pathology (Fatemi
and Folsom, 2009). Furthermore, a recent
study reported focal patches of abnormal
cortical disorganization in children diag-
nosed with ASD (Stoner et al., 2014).
The findings by Yoon et al. demonstrating
altered mouse neocortical development
after in utero knockdown of CYFIP1 are
in support of this neurodevelopmental
hypothesis for schizophrenia and ASD.
15q11.2 deletion is a rare genetic muta-
tion resulting in reduced expression of
the genes contained in this region, and it
is associated with an increased risk for
schizophrenia. However, single nucleo-
tide polymorphisms (SNPs) associated
with genes located within the 15q11.2 re-
gion did not show genome-wide signifi-
cance for association with schizophrenia.
To account for this discrepancy, Song
and colleagues hypothesized that SNPs
within genes encoding other components
of the WAVE signaling pathway might
interact to increase the risk for schizo-
phrenia. To test this, the authors con-
ducted targeted pair-wise SNP-SNP
interaction analyses for SNP variants
associated with expression of genes in
the WAVE signaling pathway. This anal-
ysis found that an interaction between
an SNP located at ACTR2 (a component
of the WAVE-interacting Arp2/3 complex)
and another SNP affecting the expression
of CYFIP1 and NIPA2 genes was signifi-
cantly associated with an increased risk
for schizophrenia. This result suggests
an epistatic interaction of WAVE signaling
pathway components affecting the risk of
schizophrenia development.
CYFIP1 was recently implicated in the
maintenance of dendritic complexity and
stabilization of mature spines in hippo-
campal neurons. The findings by Song
and colleagues provide insight into an
earlier developmental role for CYFIP1,
indicating multiple functions for this pro-
tein in brain development. Despite the
clear importance of CYFIP1 in cortical
development, it is worth noting that these
findings do not preclude a role for the
other 15q11.2del genes in neurological
dysfunction. For instance, TUBGPC5
has previously been identified as a
member of the g-tubulin complex that is
required for microtubule nucleation at
the centrosome (Murphy et al., 2001).
One could hypothesize that depletion ofier Inc.TUBGPC5 would affect cell proliferation.
Therefore, it would be interesting to
know if TUBGCP5 has a role in cortical
development, especially in neural progen-
itor proliferation.
Finally, Yoon et al. demonstrated that
iPSC technology could be successfully
used not only to study monogenic disor-
ders where disruption of a single gene
causes the disease pathology, but also
to understand diseases associated with
disruption of multiple genes (i.e. poly-
genic diseases) such as 15q11.2del. A
key challenge of studying polygenic dis-
orders is the uncertainty in contribution
of disrupted genes to disease etiology.
As was demonstrated by Yoon et al.,
targeted candidate gene selection is
possible using human iPSCs to charac-
terize phenotypes associated with dis-
rupted genes. Future studies taking
advantage of the system to study dis-
eases associated with deletion or dupli-
cation of multiple genes could give novel
insights into pathophysiological pheno-
types and mechanisms.
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